anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Quote

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 10,645
Current window 8,281-8,310
Pages 355
Rows per page 30
Component: Quoteclear collectionreset all
18 30 60

Component

8,281-8,310 of 10,645

filter-aware
213
The slide uses a Q&A format to present expert testimony regarding TransMedics' NOP (National Organ Procurement) operations.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
231
The slide uses a Q&A format to highlight a breakdown in the standard organ procurement process.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
232
The slide uses a Q&A format to highlight a potential conflict of interest or operational risk regarding TransMedics' NOP service.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
234
The slide uses a Q&A format to substantiate claims of surgical incompetence and unethical organ distribution practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
237
The slide uses a quote-heavy structure to build a narrative of corporate negligence regarding medical standards.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
238
The slide uses direct quotes from former employees to support the claim of incompetence and lack of proper medical oversight.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
241
The slide uses a quote from Congressman Paul Gosar to substantiate claims of a 'bait and switch' business model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
242
The slide uses a quote-based argument to challenge the company's stated quality control rationale.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
248
The slide uses a Q&A transcript format to substantiate claims of poor management and safety negligence.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
255
The slide uses a combination of summary text and a direct quote to highlight unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
256
The slide uses a Q&A transcript format to substantiate a serious allegation of unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
261
The slide uses a Q&A format to highlight potential malpractice and coercion.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
262
The slide presents a narrative of a specific medical failure involving a necrotic liver, alleging that TransMedics may be concealing damage from receiving centers.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
265
The slide uses a quote to highlight a perceived lack of transparency by the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
272
The slide uses a Q&A format to directly contradict claims made by the TransMedics CEO regarding reimbursement pass-through.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
276
The slide uses a Q&A format to highlight a specific expert's negative sentiment toward TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
278
The slide uses a Q&A format to build a narrative of market abandonment.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
282
The slide uses a testimonial from a transplant surgeon to support a bearish thesis on the company's market position.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
287
The slide uses highlighted text to emphasize key negative findings regarding the OCS technology's performance metrics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
296
The slide uses a direct quote from an expert to undermine the value proposition of the TransMedics device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
297
The slide uses a quote-heavy structure to undermine the investment thesis for TransMedics (TMDX).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
313
The slide uses a direct quote to highlight a competitive threat to TransMedics' business model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
325
The slide uses a direct quote to frame the current market situation as overpriced and vulnerable to disruption, drawing an analogy to the Hepatitis C drug market.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
331
Includes a direct quote from a CEO of a major OPO regarding a surgeon's resignation due to safety concerns.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
335
The slide uses a Q&A format to highlight a specific failure in the procurement process.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
338
The slide uses a quote to highlight a perceived lack of transparency by the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
339
The slide presents a narrative of institutional failure and ethical concerns regarding medical device reporting.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
340
The slide uses a Q&A format to highlight a specific expert's negative experience with TransMedics equipment and corporate communication.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
341
The slide highlights a critical failure in safety protocols and regulatory compliance as perceived by an industry expert.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
342
The slide uses highlighted text to emphasize key allegations of non-reporting and unethical behavior.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit